Developing and testing a new medication formulation for clinical trials.
THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL
['FUNDING_OTHER'] · IRISYS, INC. · NIH-11221085
This study is working on a new way to deliver a medication called ORC-13661, which could help patients by making the treatment more effective, and it will be tested in a clinical trial to ensure it's safe and works well.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IRISYS, INC. (nih funded) |
| Locations | 1 site (SAN DIEGO, UNITED STATES) |
| Trial ID | NIH-11221085 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing a new dosage form of the medication ORC-13661, which is intended for use in a Phase II clinical trial. The project involves developing the formulation, manufacturing it, and conducting stability studies to ensure the medication remains effective over time. Patients may benefit from this research as it aims to improve the delivery and effectiveness of a new treatment option. The research will follow strict protocols to ensure safety and efficacy during the trial phase.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals who are eligible for participation in Phase II clinical trials of ORC-13661.
Not a fit: Patients who do not meet the eligibility criteria for the Phase II clinical trial may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective medication formulation that improves patient outcomes.
How similar studies have performed: Similar research efforts in dosage form development have shown promise in improving medication efficacy and patient outcomes.
Where this research is happening
SAN DIEGO, UNITED STATES
- IRISYS, INC. — SAN DIEGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOURQUE, TIM — IRISYS, INC.
- Study coordinator: BOURQUE, TIM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.